Identifying risk factors for central pontine and extrapontine myelinolysis after liver transplantation: A case-control study

Neurocritical Care

Volumn 20, Issue 2, 2014, Pages 287-295

  Morard, Isabelle ^a   Gasche, Yvan ^a,b   Kneteman, Mark ^c   Toso, Christian ^a   Mentha, Ariane ^a   Meeberg, Glenda ^c   Mentha, Gilles ^a   Kneteman, Norman ^c   Giostra, Emiliano ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Central pontine and extrapontine myelinolysis; Hemorrhagic complications; Hyponatremia; MELD; Mortality; Neurological complications; Orthotopic liver transplantation

Indexed keywords

CYCLOSPORIN; FRESH FROZEN PLASMA; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; SODIUM; STEROID; TACROLIMUS;

ADULT; ARTICLE; CANADA; CASE CONTROL STUDY; CENTRAL PONTINE AND EXTRAPONTINE MYELINOLYSIS; CENTRAL PONTINE MYELINOLYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN CELL; LIVER TRANSPLANTATION; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; OUTCOME ASSESSMENT; PLASMA TRANSFUSION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SODIUM BLOOD LEVEL; SWITZERLAND; THROMBOCYTE TRANSFUSION; BLOOD; HYPONATREMIA; MIDDLE AGED; MYELINOLYSIS, CENTRAL PONTINE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPERATIVE BLOOD LOSS; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; SEVERITY OF ILLNESS INDEX;

ALBERTA; BLOOD LOSS, SURGICAL; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPONATREMIA; LIVER TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYELINOLYSIS, CENTRAL PONTINE; PATIENT OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SODIUM; SWITZERLAND;

EID: 84896547045     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-013-9928-9     Document Type: Article

References (42)

1. Adams RD, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry. 1959;81(2):154-72.
2. Wright DG, Laureno R, Victor M. Pontine and extrapontine myelinolysis. Brain. 1979;102:361-85. (Pubitemid 9161009)
3. Pfister HW, Einhaupl KM, Brandt T. Mild central pontine myelinolysis: a frequently undetected syndrome. Eur Arch Psychiatry Neurol Sci. 1985;235(3):134-9. (Pubitemid 16184385)
4. Kato T, Hattori H, Nagato M, et al. Subclinical central pontine myelinolysis following liver transplantation. Brain Dev. 2002;24(3):179-82. (Pubitemid 34273676)
5. Winnock S, Janvier G, Parmentier F, et al. Pontine myelinolysis following liver transplantation: a report of two cases. Transpl Int. 1993;6:26-8. (Pubitemid 23015179)
6. Fryer JP, Fortier M, Metrakos P, et al. Central Pontine Myelinolysis and Cyclosporine neurotoxicity following liver transplantation. Transplantation. 1996;61:658-61. (Pubitemid 26073617)
7. Bonham CA, Dominguez EA, Fukui MB, et al. Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management. Transplantation. 1998;66(12):1596-604. (Pubitemid 29034977)
8. Bronster DJ, Emre S, Boccagni P, Sheiner PA, Schwartz ME, Miller CM. Central nervous system complications in liver transplant recipients-incidence, timing, and long-term follow-up. Clin Transplant. 2002;14:1-7. (Pubitemid 30079522)
9. Yu J, Shu-Sen Z, Ting-Bo L, Yan S, Wei-Lin W, Qing-Hong K. Possible causes of central pontine myelinolysis after liver transplantation. World J Gastroenterol. 2004;10(17):2540-3. (Pubitemid 39206775)
10. Kim BS, Lee SG, Hwang S, et al. Neurologic complications in adult living donor liver transplant recipients. Clin Transplant. 2007;21:544-7. (Pubitemid 47161834)
11. Lee EM, Kang JK, Yun SC, et al. Risk factors for central pontine and extrapontine myelinolysis following orthotopic liver transplantation. Eur Neurol. 2009;62(6):362-8.
12. Yun BC, Kim WR, Benson JT, et al. Impact of pretransplant hyponatremia on outcome following liver transplantation. Hepatology. 2009;49(5):1610-5.
13. Wszolek ZK, McComb RD, Pfeiffer RF, et al. Pontine and extrapontine myelinolysis following liver transplantation. Relationship to serum sodium. Transplantation. 1989;48(6):1006-12. (Pubitemid 20018359)
14. Estol CJ, Faris AA, Martinez AJ, Ahdab-Barmada M. Central pontine myelinolysis after liver transplantation. Neurology. 1989;39:493-8. (Pubitemid 19105761)
15. Boon AP, Adams DH, Buckels JA, McMaster P. Neuropathological findings in autopsies after liver transplantation. Transplant Proc. 1991;23:1471-2.
16. Ferreiro JA, Robert MA, Townsend J, Vinters HV. Neuropathologic findings after liver transplantation. Acta Neuropathol. 1992;84(1):1-14.
17. Singh N, Yu VL, Gayowski T. Central nervous system lesions in adult liver transplant recipients: review with implications for management. Medicine. 1994;73:110-8. (Pubitemid 24114629)
18. Kleinschmidt-DeMasters BK, Rojiani AM, Filley CM. Central and extrapontine myelinolysis: then and now. J Neuropathol Exp Neurol. 2006;65:1-11.
19. Lampl C, Yazdi K. Central pontine myelinolysis. Eur Neurol. 2002;47(1):3-10.
20. Cuervas-Mons V, Martinez AJ, Dekker A, Starzl TE, Thiel DH. Adult liver transplantation: an analysis of the early causes of death in 40 consecutive cases. Hepatology. 1986;6:495-501. (Pubitemid 16086643)
21. Adams DH, Gunson B, Honigsberger L, et al. Neurological complications following liver transplantation. Lancet. 1987;1:949-51. (Pubitemid 17068583)
22. Miller GM, Baker HL, Okazaki H, Whisnant JP. Central pontine myelinolysis and its imitators: MR findings. Radiology. 1988;168:795-802.
23. Reyes J, Gayowski T, Fung J, Todo S, Alessiani M, Starzl TE. Expressive dysphasia possibly related to FK 506 in two liver transplant recipients. Transplantation. 1990;50:1043-5.
24. Bird GL, Meadows J, Goka J, Polson R, Williams R. Cyclosporin-associated akinetic mutism and extrapyramidal syndrome after liver transplantation. J Neurol Neurosurg Psychiatry. 1990;53:1068-71.
25. Boon AP, Carey MP, Adams DH, Buckels J, McMaster P. Central pontine myelinolysis in liver transplantation. J Clin Pathol. 1991;44:909-14.
26. Burkhalter EL, Starzl TE, Van Thiel DH. Severe neurological complications following orthotopic liver transplantation in patients receiving FK 506 and Prednisone. J Hepatol. 1994;21:572-7. (Pubitemid 24324032)
27. Kabeer MH, Filo RS, Milgrom ML, et al. Central pontine myelinolysis following orthotopic liver transplant: association with cyclosporin toxicity. Postgrad Med J. 1995;71(834):239-41.
28. Menger H, Jorg J. Outcome of central pontine and extrapontine myelinolysis (n = 44). J Neurol. 1999;246:700-5. (Pubitemid 29417853)
29. Murdoch M, Chang M, McVicar J. Central pontine myelinolysis after liver transplantation: a case report. Transpl Int. 1995;8(5):399-402.
30. Rodriguez J, Benito-Leon J, Molina JA, Ramos A, Bermeo F. Central Pontine myelinolysis associated with cyclosporine in liver transplantation. Neurologia. 1998;13:437-40. (Pubitemid 29028261)
31. Buis CI, Wijdicks EFM. Serial magnetic resonance imaging of central pontine myelinolysis. Liver Transplant. 2002;8:643-7.
32. Guo Y, Hu JH, Lin W, Zheng KH. Central pontine myelinolysis after liver transplantation: MR diffusion, spectroscopy and perfusion findings. Magn Reson Imaging. 2006;24:1395-8. (Pubitemid 44827589)
33. Senzolo M, Ferronato C, Burra P. Neurologic complications after solid organ transplantation. Transpl Int. 2009;22(3):269-78.
34. Bechstein WO. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int. 2000;13(5):313-26.
35. Howard SA, Barletta JA, Klufas RA, Saad A, De Girolami U. Best cases from the AFIP: osmotic demyelination syndrome. Radiographics. 2009;29:933-8.
36. Chu K, Kang DW, Ko SB, Kim M. Diffusion-weighted MR findings of central pontine and extrapontine myelinolysis. Acta Neurol Scand. 2001;104:385-8. (Pubitemid 33105113)
37. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464-70. (Pubitemid 32119037)
38. Ashrafian H, Davey D. A review of the causes of central pontine myelinolysis: yet another apoptotic illness? Eur J Neurol. 2001;8:103-9. (Pubitemid 32269628)
39. Thurston JH, Hauhart RE, Nelson JS. Adaptive increases in amino acids (taurine in particular), creatine, and electrolytes prevent cerebral edema in chronically hyponatremic mice; rapid correction (experimental model of central pontine myelinolysis) causes dehydration and shrinkage of brain. Metab Brain Dis. 1987;2:223-41. (Pubitemid 18009456)
40. Brown WD. Osmotic demyelination disorders: central pontine and extrapontine myelinolysis. Curr Opin Neurol. 2000;13:691-7. (Pubitemid 32002654)
41. Gines P, Guevara M. Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management. Hepatology. 2008;48:1002-10.
42. Fukazawa K, Nishida S, Aguina L, Pretto E Jr. Central pontine myelinolysis (CPM) associated with tacrolimus (FK506) after liver transplantation. Ann Transplant. 2011;16(3):139-42.